| Literature DB >> 32456668 |
Sharon Akinpelu1, Abraham Ajayi1,2, Stella I Smith3, Adeyemi I Adeleye1.
Abstract
OBJECTIVE: Nosocomial and community acquired multidrug resistant Klebsiella infections are wide spread resulting in high morbidity and mortality due to limited number of antibiotics treatment options. This study investigated efflux pump activity, biofilm forming potential and antibiotic susceptibility profile of Klebsiella spp. isolated from clinical samples in a tertiary hospital in Lagos Nigeria. Eighteen clinical Klebsiella spp. isolated from urine, blood and sputum were subjected to antibiotic susceptibility testing using the disc diffusion method. Efflux pump activity was evaluated by the ethidium bromide cartwheel method and biofilm forming ability was determined by the tissue culture plate technique.Entities:
Keywords: Antibiotic resistance; Biofilm; Efflux pump; Klebsiella
Mesh:
Substances:
Year: 2020 PMID: 32456668 PMCID: PMC7249407 DOI: 10.1186/s13104-020-05105-2
Source DB: PubMed Journal: BMC Res Notes ISSN: 1756-0500
Fig. 1Percentage antibiotics resistance of Klebsiella clinical isolates. CXM cefuroxime, GEN gentamicin, ZEM cefixime, OFL ofloxacin, AUG amoxicillin − clavulanate, NA nalidixic acid, CTX cefotaxime, ACX ampicillin + cloxacillin, NIT nitrofurantoin, IMI imipenem, LBC levofloxacin
Biofilm forming potential, efflux pump activity and antibiotic susceptibility profile of Klebsiella spp
| Isolate ID | Source | Biofilm forming potential | Efflux pump activity | Antibiotic resistance profile | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Strong | Moderate | Weak | Phenotypic | CXM | AUG | CTX | IMI | OFL | GEN | NA | NIT | ACX | ZEM | LBC | ||
| K51 | Urine | ✓ | + | R | R | R | R | R | R | R | R | R | R | R | ||
| K52 | Urine | ✓ | + | R | R | R | R | R | R | R | R | R | R | R | ||
| K53 | Urine | ✓ | + | R | R | R | R | R | R | R | R | R | R | R | ||
| K54 | Urine | ✓ | + | R | R | R | R | R | S | R | R | R | R | R | ||
| K55 | Urine | ✓ | + | R | R | R | R | R | R | R | S | R | R | R | ||
| K56 | Urine | ✓ | + | R | R | R | R | R | R | R | R | R | R | R | ||
| K57 | Urine | ✓ | + | R | R | R | R | R | S | R | R | R | R | R | ||
| K58 | Urine | ✓ | + | R | R | R | R | R | R | R | S | R | R | R | ||
| K59 | Urine | ✓ | + | R | R | R | R | R | R | R | R | R | R | R | ||
| K60 | Urine | ✓ | + | R | R | R | R | S | R | S | R | R | R | S | ||
| K61 | Urine | ✓ | + | R | R | R | R | R | R | R | S | R | R | S | ||
| K62 | Blood | ✓ | + | R | R | R | R | R | R | R | S | R | R | R | ||
| K63 | Sputum | ✓ | + | R | R | R | R | R | R | R | R | R | R | R | ||
| K64 | Sputum | ✓ | + | R | R | R | R | R | R | R | R | R | R | R | ||
| K65 | Urine | ✓ | + | R | R | R | R | R | R | R | R | R | S | R | ||
| K66 | Urine | ✓ | + | R | R | R | R | R | R | R | R | R | R | R | ||
| K67 | Urine | ✓ | + | R | R | R | R | R | R | R | S | R | R | R | ||
| K68 | Urine | ✓ | + | R | R | R | R | R | R | R | R | R | R | R | ||
CXM cefuroxime, GEN gentamicin, ZEM gefixime, OFL ofloxacin, AUG amoxicillin − clavulanate, NA nalidixic acid, CTX cefotaxime, ACX ampicillin + cloxacillin, NIT nitrofurantoin, IMI imipenem, LBC levofloxacin